Advocacy intelligence hub — real-time data for patient organizations
Institute of Hematology & Blood Diseases Hospital, China — PHASE2
Hiroshima University Hospital — PHASE1, PHASE2
The Affiliated Hospital of Xuzhou Medical University — PHASE2
Abcuro, Inc. — PHASE1, PHASE2
Memorial Sloan Kettering Cancer Center — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Mitchell Cairo, MD, MD
New York Medical College
📍 HAWTHORNE, NY
Alison Moskowitz, MD, LCSW
Memorial Sloan Kettering Cancer Center
📍 FAIRFIELD, CT
Wyndham H Wilson, M.D., MD, PhD
National Cancer Institute (NCI)
📍 BETHESDA, MD
Helen Heslop, MD, MD
Baylor College of Medicine
📍 HOUSTON, TX
Ryotaro Nakamura
City of Hope Medical Center
📍 Duarte, California